$486 Million is the total value of Integral Health Asset Management, LLC's 65 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 50.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ANTM | Buy | ELEVANCE HEALTH INC | $32,738,000 | +48.1% | 67,840 | +50.8% | 6.73% | +17.1% |
| CNC | Buy | CENTENE CORP DEL | $29,614,000 | +134.5% | 350,000 | +133.3% | 6.09% | +85.4% |
| LLY | New | LILLY ELI & CO | $23,688,000 | – | 73,059 | +100.0% | 4.87% | – |
| CYTK | Buy | CYTOKINETICS INC | $20,627,000 | +19.2% | 525,000 | +11.7% | 4.24% | -5.8% |
| SNY | New | SANOFIsponsored adr | $17,511,000 | – | 350,000 | +100.0% | 3.60% | – |
| GH | Buy | GUARDANT HEALTH INC | $15,543,000 | +134.6% | 385,291 | +285.3% | 3.20% | +85.4% |
| AZN | Buy | ASTRAZENECA PLCsponsored adr | $15,515,000 | +133.9% | 234,830 | +134.8% | 3.19% | +84.9% |
| NVST | Buy | ENVISTA HOLDINGS CORPORATION | $14,883,000 | +22.2% | 386,165 | +54.5% | 3.06% | -3.4% |
| CCXI | Buy | CHEMOCENTRYX INC | $14,224,000 | +41.8% | 574,029 | +43.5% | 2.93% | +12.2% |
| MCK | New | MCKESSON CORP | $13,619,000 | – | 41,748 | +100.0% | 2.80% | – |
| SAGE | Buy | SAGE THERAPEUTICS INC | $13,316,000 | +29.4% | 412,257 | +32.6% | 2.74% | +2.2% |
| THC | Buy | TENET HEALTHCARE CORP | $13,165,000 | +17.8% | 250,485 | +92.7% | 2.71% | -6.9% |
| CVS | Buy | CVS HEALTH CORP | $13,056,000 | +43.3% | 140,898 | +56.6% | 2.69% | +13.3% |
| DXCM | New | DEXCOM INC | $12,446,000 | – | 166,991 | +100.0% | 2.56% | – |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $10,465,000 | +69.7% | 126,286 | +57.9% | 2.15% | +34.1% |
| PKI | Sell | PERKINELMER INC | $9,648,000 | -26.3% | 67,840 | -9.5% | 1.98% | -41.7% |
| ZNTL | Buy | ZENTALIS PHARMACEUTICALS INC | $9,561,000 | -3.6% | 340,243 | +58.3% | 1.97% | -23.8% |
| MRK | Buy | MERCK & CO INC | $9,515,000 | +54.6% | 104,369 | +39.2% | 1.96% | +22.2% |
| SWAV | Buy | SHOCKWAVE MED INC | $8,978,000 | +44.3% | 46,966 | +56.6% | 1.85% | +14.1% |
| KURA | Buy | KURA ONCOLOGY INC | $8,456,000 | +56.0% | 461,310 | +36.9% | 1.74% | +23.3% |
| ALKS | Buy | ALKERMES PLC | $7,804,000 | +18.6% | 261,966 | +4.8% | 1.60% | -6.2% |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $7,566,000 | +256.7% | 704,490 | +214.5% | 1.56% | +181.9% |
| PRGO | New | PERRIGO CO PLC | $7,410,000 | – | 182,645 | +100.0% | 1.52% | – |
| RLAY | Buy | RELAY THERAPEUTICS INC | $7,307,000 | -25.3% | 436,262 | +33.4% | 1.50% | -41.0% |
| ALNY | New | ALNYLAM PHARMACEUTICALS INC | $6,850,000 | – | 46,966 | +100.0% | 1.41% | – |
| ICLR | New | ICON PLC | $6,785,000 | – | 31,311 | +100.0% | 1.40% | – |
| QURE | Buy | UNIQURE NV | $6,582,000 | +114.3% | 353,106 | +107.7% | 1.35% | +69.5% |
| BPMC | Sell | BLUEPRINT MEDICINES CORP | $6,566,000 | -32.8% | 130,000 | -15.0% | 1.35% | -46.9% |
| IRTC | Sell | IRHYTHM TECHNOLOGIES INC | $6,201,000 | -34.4% | 57,403 | -4.3% | 1.28% | -48.1% |
| ONEM | Buy | 1LIFE HEALTHCARE INC | $5,728,000 | +3.4% | 730,582 | +46.1% | 1.18% | -18.3% |
| MRNA | New | MODERNA INC | $5,714,000 | – | 40,000 | +100.0% | 1.18% | – |
| SGEN | Sell | SEAGEN INC | $5,540,000 | -23.1% | 31,311 | -37.4% | 1.14% | -39.2% |
| ZLAB | Buy | ZAI LAB LTDadr | $5,429,000 | +64.6% | 156,554 | +108.7% | 1.12% | +30.2% |
| AGL | Buy | AGILON HEALTH INC | $5,035,000 | +13.5% | 230,655 | +31.8% | 1.04% | -10.2% |
| CRSP | Sell | CRISPR THERAPEUTICS AGnamen akt | $4,862,000 | -35.4% | 80,010 | -33.3% | 1.00% | -49.0% |
| APLS | Buy | APELLIS PHARMACEUTICALS INC | $4,484,000 | +121.9% | 99,150 | +149.3% | 0.92% | +75.3% |
| ITCI | Buy | INTRA-CELLULAR THERAPIES INC | $4,468,000 | +82.5% | 78,277 | +95.7% | 0.92% | +44.3% |
| ZBH | Buy | ZIMMER BIOMET HOLDINGS INC | $4,386,000 | +14.3% | 41,748 | +39.2% | 0.90% | -9.6% |
| NTLA | Buy | INTELLIA THERAPEUTICS INC | $4,322,000 | +18.9% | 83,495 | +67.0% | 0.89% | -6.0% |
| PTCT | Buy | PTC THERAPEUTICS INC | $4,193,000 | +167.6% | 104,656 | +149.2% | 0.86% | +111.3% |
| DVA | New | DAVITA INC | $4,173,000 | – | 52,184 | +100.0% | 0.86% | – |
| TDOC | New | TELADOC HEALTH INC | $4,130,000 | – | 124,369 | +100.0% | 0.85% | – |
| ACRS | Buy | ACLARIS THERAPEUTICS INC | $3,992,000 | -2.7% | 285,971 | +20.2% | 0.82% | -23.1% |
| REPL | Buy | REPLIMUNE GROUP INC | $3,832,000 | +36.8% | 219,194 | +32.8% | 0.79% | +8.1% |
| MIRM | Buy | MIRUM PHARMACEUTICALS INC | $3,453,000 | +12.0% | 177,427 | +26.7% | 0.71% | -11.5% |
| NVRO | Buy | NEVRO CORP | $3,431,000 | -5.1% | 78,277 | +56.6% | 0.71% | -25.0% |
| KRYS | New | KRYSTAL BIOTECH INC | $3,426,000 | – | 52,184 | +100.0% | 0.70% | – |
| JAZZ | Sell | JAZZ PHARMACEUTICALS PLC | $3,257,000 | -40.2% | 20,874 | -40.4% | 0.67% | -52.8% |
| ITOS | Buy | ITEOS THERAPEUTICS INC | $3,225,000 | +17.9% | 156,553 | +84.2% | 0.66% | -6.9% |
| RETA | Buy | REATA PHARMACEUTICALS INCcl a | $3,172,000 | +176.5% | 104,369 | +198.2% | 0.65% | +118.8% |
| XENE | New | XENON PHARMACEUTICALS INC | $2,959,000 | – | 97,281 | +100.0% | 0.61% | – |
| HRTX | HERON THERAPEUTICS INC | $2,790,000 | -51.2% | 1,000,000 | 0.0% | 0.57% | -61.4% | |
| AKRO | Buy | AKERO THERAPEUTICS INC | $2,722,000 | -4.1% | 288,058 | +44.0% | 0.56% | -24.1% |
| ARCT | Buy | ARCTURUS THERAPEUTICS HLDGS | $2,464,000 | -26.9% | 156,553 | +25.2% | 0.51% | -42.2% |
| NSTG | New | NANOSTRING TECHNOLOGIES INC | $2,394,000 | – | 188,500 | +100.0% | 0.49% | – |
| KNSA | Buy | KINIKSA PHARMACEUTICALS LTD | $2,276,000 | +33.9% | 234,830 | +37.3% | 0.47% | +5.9% |
| LFST | Buy | LIFESTANCE HEALTH GROUP INC | $2,089,000 | +37.7% | 375,728 | +150.5% | 0.43% | +8.9% |
| SIBN | Sell | SI-BONE INC | $2,077,000 | -60.9% | 157,317 | -33.1% | 0.43% | -69.1% |
| INSM | Sell | INSMED INC | $2,058,000 | -41.6% | 104,369 | -30.4% | 0.42% | -53.9% |
| ATRA | Sell | ATARA BIOTHERAPEUTICS INC | $1,626,000 | -41.7% | 208,738 | -30.4% | 0.33% | -53.9% |
| FMTX | Buy | FORMA THERAPEUTICS HLDGS INC | $896,000 | +7.0% | 130,051 | +44.5% | 0.18% | -15.6% |
| New | CINCOR PHARMA INC | $787,000 | – | 41,748 | +100.0% | 0.16% | – | |
| LXRX | New | LEXICON PHARMACEUTICALS INC | $558,000 | – | 300,000 | +100.0% | 0.12% | – |
| MGTA | Buy | MAGENTA THERAPEUTICS INC | $394,000 | -32.4% | 328,269 | +63.3% | 0.08% | -46.7% |
| LBPH | Buy | LONGBOARD PHARMACEUTICALS IN | $177,000 | -30.3% | 57,335 | +20.5% | 0.04% | -45.5% |
| Exit | AVALO THERAPEUTICS INC | $0 | – | -700,000 | -100.0% | -0.13% | – | |
| CMRX | Exit | CHIMERIX INC | $0 | – | -119,000 | -100.0% | -0.14% | – |
| DNLI | Exit | DENALI THERAPEUTICS INC | $0 | – | -26,000 | -100.0% | -0.22% | – |
| SRRA | Exit | SIERRA ONCOLOGY INC | $0 | – | -30,000 | -100.0% | -0.25% | – |
| PMVP | Exit | PMV PHARMACEUTICALS INC | $0 | – | -50,000 | -100.0% | -0.27% | – |
| DTIL | Exit | PRECISION BIOSCIENCES INC | $0 | – | -350,000 | -100.0% | -0.28% | – |
| INCY | Exit | INCYTE CORP | $0 | – | -18,000 | -100.0% | -0.37% | – |
| DOCS | Exit | DOXIMITY INCcl a | $0 | – | -30,000 | -100.0% | -0.41% | – |
| ICPT | Exit | INTERCEPT PHARMACEUTICALS IN | $0 | – | -125,000 | -100.0% | -0.53% | – |
| INSP | Exit | INSPIRE MED SYS INC | $0 | – | -10,000 | -100.0% | -0.67% | – |
| TFX | Exit | TELEFLEX INCORPORATED | $0 | – | -8,000 | -100.0% | -0.74% | – |
| RGNX | Exit | REGENXBIO INC | $0 | – | -90,000 | -100.0% | -0.78% | – |
| BIIB | Exit | BIOGEN INC | $0 | – | -15,000 | -100.0% | -0.82% | – |
| NBIX | Exit | NEUROCRINE BIOSCIENCES INC | $0 | – | -35,000 | -100.0% | -0.85% | – |
| KROS | Exit | KEROS THERAPEUTICS INC | $0 | – | -81,000 | -100.0% | -1.15% | – |
| ISRG | Exit | INTUITIVE SURGICAL INC | $0 | – | -16,000 | -100.0% | -1.26% | – |
| CI | Exit | CIGNA CORP NEW | $0 | – | -25,000 | -100.0% | -1.56% | – |
| AMED | Exit | AMEDISYS INC | $0 | – | -40,000 | -100.0% | -1.79% | – |
| ACHC | Exit | ACADIA HEALTHCARE COMPANY IN | $0 | – | -150,000 | -100.0% | -2.56% | – |
| GMED | Exit | GLOBUS MED INCcl a | $0 | – | -180,000 | -100.0% | -3.46% | – |
| PFE | Exit | PFIZER INC | $0 | – | -300,000 | -100.0% | -4.04% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-03
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CYTOKINETICS INC | 15 | Q3 2023 | 4.7% |
| SAGE THERAPEUTICS INC | 15 | Q2 2023 | 5.0% |
| BIOMARIN PHARMACEUTICAL INC | 15 | Q2 2023 | 4.1% |
| ENVISTA HOLDINGS CORPORATION | 14 | Q3 2023 | 4.0% |
| AKERO THERAPEUTICS INC | 14 | Q3 2023 | 1.5% |
| REVVITY INC | 13 | Q3 2023 | 4.2% |
| BLUEPRINT MEDICINES CORP | 13 | Q3 2023 | 3.3% |
| PTC THERAPEUTICS INC | 13 | Q2 2023 | 1.7% |
| ELEVANCE HEALTH INC | 12 | Q3 2023 | 6.7% |
| NEVRO CORP | 12 | Q4 2022 | 4.5% |
View Integral Health Asset Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-09 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-03 |
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-02-02 |
| 13F-HR | 2021-11-12 |
View Integral Health Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.